A bill to require drug manufacturers to report certain information to the department of insurance and financial services; to provide for the powers and duties of certain state officers and entities; to allow for the promulgation of rules; and to prescribe civil sanctions.
House Bill 4409 would create a new act, the Drug Manufacturer Data Reporting Act, which would require drug manufacturers to disclose certain information on costs and pricing to the Department of Insurance and Financial Services (DIFS) on an annual basis. The reports and information would be exempt from disclosure under the Freedom of Information Act (FOIA). DIFS could promulgate rules to implement the act.
Co-sponsored by Reps.
Referred to the Committee on Health Policy
Reported without amendment
Passed in the House 90 to 20 (details)
Motion to give immediate effect
by
The motion prevailed by voice vote
Referred to the Committee on Health Policy
